alastair gray

Sitert av

	Alle	Siden 2020
Sitater	53540	19812
h-indeks	110	63
i10-indeks	382	260

4200

2100

1050

3150

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025177 247 359 427 481 560 566 663 825 980 1041 1100 1341 1517 1791 2377 2550 2771 3007 3031 3100 3451 3596 3901 4130 3870 3504 759

Offentlig tilgang

Vis alle

222 artikler

10 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Borislava MihaylovaUniversity of Oxford, Queen Mary University of LondonVerifisert e-postadresse på dph.ox.ac.uk
Philip ClarkeProfessor of health economics, university of melbourneVerifisert e-postadresse på unimelb.edu.au
david p taggartProfessor of Cardiovascular Surgery Oxford UniversityVerifisert e-postadresse på ouh.nhs.uk
Oliver Rivero-AriasAssociate Professor, University of OxfordVerifisert e-postadresse på npeu.ox.ac.uk
Marcus FlatherUniversity of East AngliaVerifisert e-postadresse på uea.ac.uk
Andrew BriggsLondon School of Hygiene & Tropical MedicineVerifisert e-postadresse på lshtm.ac.uk
Umberto BenedettoUniversity of BristolVerifisert e-postadresse på bristol.ac.uk
Helen A DakinHealth Economics Research Centre, University of Oxford, UKVerifisert e-postadresse på ndph.ox.ac.uk
Colin BaigentProfessor of Epidemiology, Oxford UniversityVerifisert e-postadresse på ctsu.ox.ac.uk
Douglas G AltmanCentre for Statistics in Medicine, University of OxfordVerifisert e-postadresse på csm.ox.ac.uk
Mike RaynerProfessor of Population Health, University of OxfordVerifisert e-postadresse på dph.ox.ac.uk
Andrew FarmerProfessor of General Practice, University of OxfordVerifisert e-postadresse på phc.ox.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsVerifisert e-postadresse på lse.ac.uk
Andrew J CarrNuffield Professor of Orthopaedic Surgery, University of OxfordVerifisert e-postadresse på ndorms.ox.ac.uk
Ray FitzpatrickUniversity of OxfordVerifisert e-postadresse på nuffield.ox.ac.uk
David J BeardUniversity of OxfordVerifisert e-postadresse på ndorms.ox.ac.uk
Peter RothwellUniversity of OxfordVerifisert e-postadresse på clneuro.ox.ac.uk
Peter ScarboroughUniversity of OxfordVerifisert e-postadresse på phc.ox.ac.uk
Nigel ArdenUniversity of OxfordVerifisert e-postadresse på ndorms.ox.ac.uk
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of LeicesterVerifisert e-postadresse på le.ac.uk

Følg

alastair gray

Emeritus Professor of Health Economics, University of Oxford

Verifisert e-postadresse på dph.ox.ac.uk

health economics


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010	4575*	2010
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ... Lancet (London, England) 380 (9841), 581-590, 2012	2453	2012
The economic burden of back pain in the UK N Maniadakis, A Gray Pain 84 (1), 95-103, 2000	2232	2000
Economic burden of cancer across the European Union: a population-based cost analysis R Luengo-Fernandez, J Leal, A Gray, R Sullivan The lancet oncology 14 (12), 1165-1174, 2013	1305	2013
Economic burden of cardiovascular diseases in the enlarged European Union J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner European heart journal 27 (13), 1610-1619, 2006	1140	2006
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019	1041	2019
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022	1035*	2022
European cardiovascular disease statistics 2012 M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...	998	2012
Applied methods of cost-effectiveness analysis in healthcare AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth OUP Oxford, 2010	890	2010
European cardiovascular disease statistics S Allender, P Scarborough, V Peto, M Rayner, J Leal, ... European Heart Network 3, 11-35, 2008	867	2008
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ... Diabetologia 47, 1747-1759, 2004	807	2004
Knee replacement AJ Price, A Alvand, A Troelsen, JN Katz, G Hooper, A Gray, A Carr, ... The Lancet 392 (10158), 1672-1682, 2018	776	2018
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) P Clarke, A Gray, R Holman Medical Decision Making 22 (4), 340-349, 2002	624	2002
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial JN Primrose, R Perera, A Gray, P Rose, A Fuller, A Corkhill, S George, ... Jama 311 (3), 263-270, 2014	551	2014
Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial DJ Beard, JL Rees, JA Cook, I Rombach, C Cooper, N Merritt, BA Shirkey, ... The Lancet 391 (10118), 329-338, 2018	521	2018
European cardiovascular disease statistics J Leal, R Luengo-Fernandez, A Gray British Heart Foundation, 2000	521	2000
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom … AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke Diabetologia 56, 1925-1933, 2013	511	2013
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ... Bmj 320 (7246), 1373-1378, 2000	485	2000
Handling uncertainty when performing economic evaluation of healthcare interventions. AH Briggs, AM Gray Health technology assessment (Winchester, England) 3 (2), 1-134, 1999	474	1999
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PD Med Collaborative Group The Lancet 384 (9949), 1196-1205, 2014	473	2014

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere